Novel asymmetric diesters of 1,4-dihydro-2,-dimethyl-pyridine-3,

Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acid esters

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

564336, C07C 6972

Patent

active

049688324

ABSTRACT:
Novel antihypertensive and coronary dilating asymmetric diesters of 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylic acid (or the stereoisomers or pharmaceutically acceptable acid addition salts thereof) have the general formula (I): ##STR1## wherein Ph is phenyl, Ar is 2-nitrophenyl, 3-nitrophenyl, 2,3-dichlorophenyl or benzofurazan-4-yl, A is a straight or branched chain alkylene radical having from 2 to 6 carbon atoms, R is a straight or branched chain alkyl radical having from 1 to 6 carbon atoms, optionally mono-substituted by an alkoxy substituent having from 1 to 6 carbon atoms, R.sub.1 is hydrogen, hydroxy or an alkyl radical having from 1 to 4 carbon atoms, and R.sub.2 is hydrogen or methyl. The subject diesters are facilely prepared from the aldehydes ArCHO and esters of acetoacetic and 3-aminocrotonic acids.

REFERENCES:
Yamato et al., Chemical Abstracts, 88:37398d.
Shimizu et al., Chemical Abstracts, 81:86039b.
Aritomi et al., Chemical Abstracts, 75:140788 m, 1971.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Novel asymmetric diesters of 1,4-dihydro-2,-dimethyl-pyridine-3, does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel asymmetric diesters of 1,4-dihydro-2,-dimethyl-pyridine-3,, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel asymmetric diesters of 1,4-dihydro-2,-dimethyl-pyridine-3, will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1307971

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.